● Live Tracking 375+ pre-IPO companies with institutional-grade data — updated daily. 140 in active pipeline.

Absci IPO Status 2026

Generative AI drug design company using AI and cell biology to create better biologics faster.

IndustryBiotechnology
StageSeries C
IPO StatusPrivate
Valuation$2.3B
Total Funding$225M
HeadquartersVancouver, WA
CEOSean McClain
How to Invest in Absci
Pre-IPO
🔔 Get Notified When Absci IPOs

No secondary market access for Absci yet. Get instant alerts when an S-1 is filed or IPO date is announced.

Get IPO Alerts →
📡 IPO Intelligence
$49/mo — Unlimited Reports + Real-Time Updates
⚡Unlimited company analysis reports — all 375+ companies
✓Real-time IPO alerts — know the moment S-1s are filed
✓Verified data updated daily — not chatbot hallucinations
💡 Tracking multiple companies? Full access pays for itself after 3 reports.
$49
per month
Subscribe Now →
Cancel anytime · Secure via Stripe
Institutional Research
$19 — Get the Complete Absci Analysis Brief
✓Executive summary & IPO readiness breakdown
✓Competitive positioning & funding trajectory
✓Bull / bear thesis with pricing projections
✓S-1 timeline estimate & risk assessment
$19
One-time
Secure checkout · Stripe · 24h delivery

Frequently Asked Questions

What is Absci's current valuation? +

Absci is valued at $2.3B as of May 2021.

How much total funding has Absci raised? +

Absci has raised $225M in total venture capital funding.

What sector is Absci in? +

Absci is a Biotechnology company. Generative AI drug design company using AI and cell biology to create better biologics faster.

What is Absci's IPO readiness score? +

Absci scores 66/100 on TechStackIPO's IPO readiness index, which evaluates funding stage, valuation trajectory, S-1 filing status, and market timing signals.